PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | 0.0% | 644 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 644 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 644 | -24.5% | 0.00% | – |
| Q3 2019 | $2,000 | -33.3% | 853 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 853 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 853 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 853 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 853 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | -33.3% | 853 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -98.9% | 853 | -97.1% | 0.00% | -100.0% |
| Q2 2014 | $283,000 | -83.4% | 29,644 | -85.5% | 0.00% | -84.6% |
| Q1 2014 | $1,701,000 | – | 204,719 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |